PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Stroke10.5853/jos.2016.009272017191104-106Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesKonark Malhotra, Monica Khunger, David S Liebeskindhttp://j-stroke.org/journal/view.php?doi=10.5853/jos.2016.00927, http://j-stroke.org/upload/pdf/jos-2016-00927.pdf, http://j-stroke.org/upload/pdf/jos-2016-00927.pdf
Journal of Stroke10.5853/jos.2016.001572016182138-145Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesHans-Christoph Diener, Christoph Kleinschnitzhttp://j-stroke.org/upload/pdf/jos-2016-00157.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2016.00157
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_7201677-89New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-vitamin K Antagonist Oral AnticoagulantsTomohisa Nezu, Yoshiki Yagitahttp://link.springer.com/content/pdf/10.1007/978-981-10-1878-7_7
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_2201611-23Recurrence of Stroke in Patients with AF Using NOACsYasushi Uenohttp://link.springer.com/content/pdf/10.1007/978-981-10-1878-7_2
Journal of Stroke10.5853/jos.2016.000522016182169-178Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsOh Young Bang, Keun-Sik Hong, Ji Hoe Heohttp://j-stroke.org/upload/pdf/jos-2016-00052.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2016.00052
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_120161-10Secondary Prevention of Stroke with Atrial Fibrillation by New Oral AnticoagulantsK. Kamiyama, T. Osato, H. Nakamurahttp://link.springer.com/content/pdf/10.1007/978-981-10-1878-7_1
Clinical and Translational Medicine10.1186/s40169-017-0179-9201871Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patientsTaizen Nakase, Junta Moroi, Tatsuya Ishikawahttp://link.springer.com/content/pdf/10.1186/s40169-017-0179-9.pdf, http://link.springer.com/article/10.1186/s40169-017-0179-9/fulltext.html, http://link.springer.com/content/pdf/10.1186/s40169-017-0179-9.pdf
Heart Rhythm10.1016/j.hrthm.2017.01.0252017144606-607Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke preventionJay A. Montgomery, Gregory F. Michaudhttp://api.elsevier.com/content/article/PII:S1547527117300723?httpAccept=text/plain, http://api.elsevier.com/content/article/PII:S1547527117300723?httpAccept=text/xml
International Journal of General Medicine10.2147/ijgm.s627602015283Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary careRenato Lopes, Patricia Guimaraes, Scott Kaatzhttps://www.dovepress.com/getfile.php?fileID=26932
Treatment of Non-vitamin K Antagonist Oral Anticoagulants10.1007/978-981-10-1878-7_8201691-99Putaminal Hemorrhage in Patients with Oral Anticoagulants: Course of Treatment and Results of Endoscopic EvacuationNobuhisa Matsushita, Masaaki Unohttp://link.springer.com/content/pdf/10.1007/978-981-10-1878-7_8